Evolution of VHL tumourigenesis in nerve root tissue
Authors:
- 18 September 2006
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 210 (3) , 374-382
Abstract
Haemangioblastomas are the key central nervous system manifestation of von Hippel–Lindau (VHL) disease, which is caused by germline mutation of the VHL gene. We have recently shown that ‘tumour‐free’ spinal cord from patients with VHL disease contains microscopic, poorly differentiated cellular aggregates in nerve root tissue, which we descriptively designated ‘mesenchymal tumourlets’. Here we have investigated spinal cord tissue affected by multiple tumours. We show that a small subset of mesenchymal tumourlets extends beyond the nerve root to form proliferative VHL‐deficient mesenchyme and frank haemangioblastoma. We thus demonstrate that tumourlets present potential, but true precursor material for haemangioblastoma. We further show that intraradicular tumourlets consist of scattered VHL‐deficient cells with activation of HIF‐2α and HIF‐dependent target proteins including CAIX and VEGF, and are associated with an extensive angiogenic response. In contrast, activation of HIF‐1α was only observed in the later stages of tumour progression. In addition, ultrastructural examination reveals gradual transition from poorly differentiated VHL‐deficient cells into vacuolated cells with a ‘stromal’ cell phenotype. The evolution of frank haemangioblastoma seems to involve multiple steps from a large pool of precursor lesions. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Epididymal cystadenomas and epithelial tumourlets: effects of VHL deficiency on the human epididymisThe Journal of Pathology, 2006
- Effects of VHL Deficiency on Endolymphatic Duct and SacCancer Research, 2005
- Developmental effects of von Hippel–Lindau gene deficiencyAnnals of Neurology, 2004
- Lumen Formation In Vivo Versus In Vitro ObservationsMicrocirculation, 2003
- Molecular basis of the VHL hereditary cancer syndromeNature Reviews Cancer, 2002
- Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor SuppressorJournal of Biological Chemistry, 2001
- The role of vascular endothelial growth factor in blood vessel formationTrends in Cell Biology, 1996
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989